- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07165496
- Original Trial
Text Messaging to Promote HIV Testing in Gay Men
November 18, 2025 updated by: Luis Menacho Alvirio, Universidad Peruana Cayetano Heredia
Cell Phones for Bringing Gay Men From Internet to the Health Center
The rate of HIV and other sexually transmitted infections (STIs) remains high among Peruvian men who have sex with men (MSM), and new prevention programs should be developed to reach and provide sexual health services to more MSM.
The Internet is a feasible medium both for recruiting participants and for implementing projects with MSM in Lima, Peru.
Likewise, in Peru, mobile phones are promising tools for carrying out HIV-related interventions due to the high rate of mobile phone penetration.
The Internet is a way to reach MSM who do not attend traditional health centers due to the stigma associated with being homosexual.
Since mobile phones can be used to promote health, the investigators proposed to design, implement, and evaluate an intervention using text messages to promote HIV testing among Peruvian MSM recruited online.
To achieve this objective, the investigators conducted a randomized controlled trial to assess the efficacy of a text message-based intervention to promote HIV testing among MSM in Lima recruited via the Internet.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lima Province
-
Lima, Lima Province, Peru
- Universidad Peruana Cayetano Heredia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Be male at birth
- Be 18 years of age or older
- Be a resident of Lima, Peru
- Report having had sex (oral or anal) with another man in the past 12 months
- Provide informed consent
- Own a mobile phone
Exclusion Criteria:
- Report being HIV-positive
- Have taken an HIV test within the past year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
Participants received weekly text messages to promote health and HIV testing and were followed and supported by trained healthcare counselors through two-way communication.
Participants were able to set up an appointment for HIV testing at no charge.
|
Participants received weekly text messages to promote health and HIV testing and were followed and supported by trained healthcare counselors through two-way communication over a 12-week period.
They were able to schedule a free HIV testing appointment at any time up to six months after enrollment.
|
|
No Intervention: Control arm
Participants were able to set up an appointment for HIV testing at no charge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants who received an HIV test
Time Frame: From enrollment to the end of the 6-month follow-up period
|
Having undergone HIV testing at one of the study-affiliated health centers
|
From enrollment to the end of the 6-month follow-up period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2015
Primary Completion (Actual)
December 31, 2015
Study Completion (Actual)
December 31, 2015
Study Registration Dates
First Submitted
September 2, 2025
First Submitted That Met QC Criteria
September 2, 2025
First Posted (Estimated)
September 10, 2025
Study Record Updates
Last Update Posted (Actual)
November 24, 2025
Last Update Submitted That Met QC Criteria
November 18, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 62406
- S6 0541-01-10 (Other Grant/Funding Number: Grand Challenges Canada)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Testing
-
New York UniversityCompletedHIV TestingUnited States
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
State University of New York at BuffaloYale University Center for Interdisciplinary Research on AIDSNot yet recruitingHIV Prevention | HIV Testing | Sexual and Reproductive HealthUnited States
-
New York Blood CenterTerminated
-
University of South CarolinaDuke University; Kilimanjaro Christian Medical Centre, TanzaniaCompletedHIV TestingUnited States, Tanzania
-
Universidad Peruana Cayetano HerediaNational Institutes of Health (NIH); NGO Via LibreCompleted
-
Catholic Relief ServicesCenters for Disease Control and PreventionCompleted
-
Catholic Relief ServicesCenters for Disease Control and PreventionCompleted
-
New York Blood CenterCompleted
Clinical Trials on Text message-based intervention
-
Emory UniversityNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
University of PennsylvaniaCompletedColonoscopy | Adherence, Patient | Text MessagingUnited States
-
Thomas Jefferson UniversityCompletedChronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Thomas Jefferson UniversityWithdrawnAcute Myeloid LeukemiaUnited States
-
Arizona State UniversityCompleted
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingTobacco-Related CarcinomaUnited States
-
University of WashingtonHope FoundationCompletedInsomnia | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States
-
Massachusetts General HospitalCompletedHypertension | Type2 Diabetes | HyperlipemiaUnited States
-
Samanta Winck MadrugaUnknown
-
Dokuz Eylul UniversityActive, not recruitingType 2 Diabetes Mellitus (T2DM) | Patient Activation | Diabetes Self-management | Diabetes Mellitus (DM)Turkey